title: Proton Pump Inhibitors and the Prescribing Cascade.
abstract: ACTIVITY OBJECTIVES: 1. Describe the prescribing cascade of proton pump inhibitors (PPI) in nursing home residents. 2. Identify the statistically significant factors related to the use of PPI and H2 receptor blockers. DISCLOSURE STATEMENT Neither the planners nor the authors have any conflicts of interest to disclose. The current study examined the use of proton pump inhibitor (PPI) drugs in 248 nursing home residents and factors associated with being prescribed a PPI. Ninety-three percent of residents taking a PPI had done so for longer than recommended durations. As anticholinergic burden, vitamin/supplement use, and number of oral products taken daily increased, residents were more likely to be taking a PPI. Higher anticholinergic burden (p = 0.031) and number of oral products taken daily (p = 0.04) were two statistically significant predictors in the final logistic regression model. Significant predictors of PPI use in the current study may be explained by the association between polypharmacy and dyspepsia and the lowering of esophageal sphincter pressure by anticholinergic drugs. High use of PPIs in nursing home residents may represent a prescribing cascade.
authors.forename: Mohammad
authors.initials: M
authors.lastname: Rababa
authors.forename: Amal Ali
authors.initials: AA
authors.lastname: Al-Ghassani
authors.forename: Christine R
authors.initials: CR
authors.lastname: Kovach
authors.forename: Elaine M
authors.initials: EM
authors.lastname: Dyer
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D018680:Cholinergic Antagonists / Q000627:therapeutic use; D003430:Cross-Sectional Studies; D004415:Dyspepsia / Q000453:epidemiology; D005260:Female; D006635:Histamine H2 Antagonists / Q000627:therapeutic use; D006801:Humans; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D009735:Nursing Homes; D019338:Polypharmacy; D054328:Proton Pump Inhibitors / Q000627:therapeutic use*
chemical_list: D018680:Cholinergic Antagonists; D006635:Histamine H2 Antagonists; D054328:Proton Pump Inhibitors